ZA200308844B - Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease. - Google Patents

Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.

Info

Publication number
ZA200308844B
ZA200308844B ZA200308844A ZA200308844A ZA200308844B ZA 200308844 B ZA200308844 B ZA 200308844B ZA 200308844 A ZA200308844 A ZA 200308844A ZA 200308844 A ZA200308844 A ZA 200308844A ZA 200308844 B ZA200308844 B ZA 200308844B
Authority
ZA
South Africa
Prior art keywords
quinuclidines
heteroaryls
cyclic
disease
substituted
Prior art date
Application number
ZA200308844A
Inventor
Donn G Wishka
Steven C Reitz
David W Piotrowski
Vincent E Groppi Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200308844B publication Critical patent/ZA200308844B/en

Links

ZA200308844A 2001-06-12 2003-11-13 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease. ZA200308844B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29771001P 2001-06-12 2001-06-12

Publications (1)

Publication Number Publication Date
ZA200308844B true ZA200308844B (en) 2004-06-28

Family

ID=34078858

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200308844A ZA200308844B (en) 2001-06-12 2003-11-13 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.

Country Status (1)

Country Link
ZA (1) ZA200308844B (en)

Similar Documents

Publication Publication Date Title
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
GB0112343D0 (en) Well treatment
ZA200309977B (en) Arylamines for the treatment of conditions associated with GSK-3.
IL196301A0 (en) Medicament for the treatment of hapatitis c
EP1390029A4 (en) Phenylindoles for the treatment of hiv
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
MXPA03006268A (en) Therapeutic chromone compounds.
HK1064261A1 (en) Method for the treatment of tobacco.
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
PL369402A1 (en) Use for the treatment of gastroesophageal reflux disease
MXPA03003032A (en) Combination therapy for the treatment of estrogen-sensitive disease.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
GB0127384D0 (en) Well treatment system
GB0029524D0 (en) Disease treatment
GB0128628D0 (en) Disease treatment
MXPA03009210A (en) New process for the preparation of oxabispidines.
ZA200308844B (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
GB2397018B (en) Combination therapy for treating disease
AP2004002980A0 (en) The treatment of lipodystrophy.
AU2002324469A1 (en) Substituted-heteroaryl-7-aza(2.2.1)bicycloheptanes for the treatment of disease
AU2002309857A1 (en) Vaccines for the treatment of autoimmune disease
GB0120788D0 (en) The treatment of kidney disease
GB0130694D0 (en) Treatment